| Literature DB >> 29795066 |
Iris H Wei1, Julio Garcia-Aguilar2.
Abstract
The management of locally-advanced rectal cancer involves a combination of chemotherapy, chemoradiation, and surgical resection to provide excellent local tumor control and overall survival. However, aspects of this multimodality approach are associated with significant morbidity and long-term sequelae. In addition, there is growing evidence that patients with a clinical complete response to chemotherapy and chemoradiation treatments may be safely offered initial non-operative management in a rigorous surveillance program. Weighed against the morbidity and significant sequelae of rectal resection, recognizing how to best optimize non-operative strategies without compromising oncologic outcomes is critical to our understanding and treatment of this disease.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29795066 PMCID: PMC6252165 DOI: 10.23736/S0026-4733.18.07743-X
Source DB: PubMed Journal: Minerva Chir ISSN: 0026-4733 Impact factor: 1.000